Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.

Surgical Scar Clinical Trial

Official title: Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.

Status Terminated

Clinical Trial Summary

Up to 25 subjects will be enrolled. Enrolled subjects will received on Ulthera® treatment on one half of their surgical scar. Follow up visits will occur at 30, 90 and 180 days after treatment. Study images will be obtained before treatment, immediately after treatment and at each follow-up visit.

Clinical Trial Description

This is a prospective, single-center, pilot clinical trial to evaluate the efficacy of the Ulthera® system to improve the appearance of scar tissue on the neck, abdomen or back. Changes from baseline of the Patient Observer Scar Assessment Scale score will be assessed at study follow-up visits. Images will be obtained prior to treatment and at each follow up visit. Patient satisfaction questionnaires will also be obtained. ;

Related Conditions & MeSH terms

• Surgical Scar

• NCT number: NCT01883414
• Study type: Interventional
• Source: Merz Pharmaceuticals, LLC
• Status: Terminated
• Phase: N/A
• Start date: June 2013
• Completion date: February 2014